@mastersthesis{MTMT:33734711,
	title = {PULMONARY ASSESSMENT OF PATIENTS WITH MARFAN SYNDROME},
	url = {https://m2.mtmt.hu/api/publication/33734711},
	author = {Kolonics-Farkas, Abigél Margit},
	doi = {10.14753/SE.2022.2572},
	unique-id = {33734711},
	year = {2022},
	orcid-numbers = {Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786}
}

@article{MTMT:32736492,
	title = {Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe},
	url = {https://m2.mtmt.hu/api/publication/32736492},
	author = {Seidl, Elias and Schwerk, Nicolaus and Carlens, Julia and Wetzke, Martin and Cunningham, Steve and Emiralioglu, Nagehan and Kiper, Nural and Lange, Joanna and Krenke, Katarzyna and Ullmann, Nicola and Krikovszky, Dóra and Maqhuzu, Phillen and Griese, Charlotte A. and Schwarzkopf, Larissa and Griese, Matthias},
	doi = {10.1136/thoraxjnl-2021-217751},
	journal-iso = {THORAX},
	journal = {THORAX},
	volume = {78},
	unique-id = {32736492},
	issn = {0040-6376},
	year = {2022},
	eissn = {1468-3296},
	pages = {781-789},
	orcid-numbers = {Cunningham, Steve/0000-0001-7342-251X; Kiper, Nural/0000-0003-1261-7393; Lange, Joanna/0000-0003-4165-6455; Ullmann, Nicola/0000-0003-1111-5690; Krikovszky, Dóra/0000-0002-0937-2121; Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786}
}

@article{MTMT:32856970,
	title = {Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF)},
	url = {https://m2.mtmt.hu/api/publication/32856970},
	author = {Nagy, Alexandra and Palmer, Erik József and Bárczi, Enikő and Kolonics-Farkas, Abigél Margit and Erdélyi, Tamás and Vincze, Krisztina and Eszes, Noémi and Bohács, Anikó and Müller, Veronika},
	doi = {10.1183/13993003.congress-2021.PA2376},
	journal-iso = {EUR RESPIR J},
	journal = {EUROPEAN RESPIRATORY JOURNAL},
	volume = {58},
	unique-id = {32856970},
	issn = {0903-1936},
	year = {2021},
	eissn = {1399-3003},
	orcid-numbers = {Nagy, Alexandra/0000-0001-8713-9256; Palmer, Erik József/0000-0002-2572-2099; Bárczi, Enikő/0000-0001-9644-4172; Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Erdélyi, Tamás/0000-0002-5025-8769; Vincze, Krisztina/0000-0002-3667-5371; Eszes, Noémi/0000-0001-8000-2265; Bohács, Anikó/0000-0002-8229-4254; Müller, Veronika/0000-0002-1398-3187}
}

@article{MTMT:32551768,
	title = {Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries},
	url = {https://m2.mtmt.hu/api/publication/32551768},
	author = {Kolonics-Farkas, Abigél Margit and Šterclová, Martina and Mogulkoc, Nesrin and Lewandowska, Katarzyna and Müller, Veronika and Hájková, Marta and Kramer, Mordechai and Jovanovic, Dragana and Tekavec-Trkanjec, Jasna and Studnicka, Michael and Stoeva, Natalia and Littnerová, Simona and Vašáková, Martina},
	doi = {10.3389/fmed.2021.729203},
	journal-iso = {FRONT MED},
	journal = {FRONTIERS IN MEDICINE},
	volume = {8},
	unique-id = {32551768},
	keywords = {Central-Eastern Europe; IPF; registry analysis; treatment; regional accessibility},
	year = {2021},
	eissn = {2296-858X},
	orcid-numbers = {Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Müller, Veronika/0000-0002-1398-3187}
}

@article{MTMT:32551601,
	title = {Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline},
	url = {https://m2.mtmt.hu/api/publication/32551601},
	author = {Nagy, Alexandra and Nagy, Tamás and Kolonics-Farkas, Abigél Margit and Eszes, Noémi and Vincze, Krisztina and Bárczi, Enikő and Tárnoki, Ádám Domonkos and Tárnoki, Dávid László and Nagy, György and Kiss, Emese and Maurovich-Horvat, Pál and Bohács, Anikó and Müller, Veronika},
	doi = {10.3389/fphar.2021.778649},
	journal-iso = {FRONT PHARMACOL},
	journal = {FRONTIERS IN PHARMACOLOGY},
	volume = {12},
	unique-id = {32551601},
	keywords = {autoimmune disease; treatment; connective tissue disease (CTD); antifibrotics; interstitiais pneumonia with autoimmune features ( IPAF); Progressive-fibrosing interstitial lung disease )PF-ILD)},
	year = {2021},
	eissn = {1663-9812},
	orcid-numbers = {Nagy, Alexandra/0000-0001-8713-9256; Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Eszes, Noémi/0000-0001-8000-2265; Vincze, Krisztina/0000-0002-3667-5371; Bárczi, Enikő/0000-0001-9644-4172; Tárnoki, Ádám Domonkos/0000-0001-5909-3780; Tárnoki, Dávid László/0000-0002-7001-7647; Nagy, György/0000-0003-1198-3228; Kiss, Emese/0000-0002-5399-2379; Maurovich-Horvat, Pál/0000-0003-0885-736X; Bohács, Anikó/0000-0002-8229-4254; Müller, Veronika/0000-0002-1398-3187}
}

@misc{MTMT:32061688,
	title = {Szisztémás autoimmun kórkép- interstitialis tüdőbetegség (CTD-ILD) hazai betegjellemzői és terápiás lehetőségek. A MAGYAR TÜDŐGYÓGYÁSZ TÁRSASÁG ALLERGOLÓGIAI ÉS LÉGZÉSPATHOLÓGIAI, VALAMINT ILD SZEKCIÓINAK TUDOMÁNYOS ÜLÉSE 2021.05.27-29.},
	url = {https://m2.mtmt.hu/api/publication/32061688},
	author = {Nagy, Tamás and Nagy, Alexandra and Eszes, Noémi and Bohács, Anikó and Palmer, Erik József and Bárczi, Enikő and Kolonics-Farkas, Abigél Margit and Tárnoki, Ádám Domonkos and Tárnoki, Dávid László and Karlinger, Kinga and Müller, Veronika and Vincze, Krisztina},
	unique-id = {32061688},
	year = {2021},
	orcid-numbers = {Nagy, Alexandra/0000-0001-8713-9256; Eszes, Noémi/0000-0001-8000-2265; Bohács, Anikó/0000-0002-8229-4254; Palmer, Erik József/0000-0002-2572-2099; Bárczi, Enikő/0000-0001-9644-4172; Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Tárnoki, Ádám Domonkos/0000-0001-5909-3780; Tárnoki, Dávid László/0000-0002-7001-7647; Karlinger, Kinga/0000-0002-0846-6687; Müller, Veronika/0000-0002-1398-3187; Vincze, Krisztina/0000-0002-3667-5371}
}

@article{MTMT:31936034,
	title = {Airway obstruction can be better predicted using Global Lung Function Initiative spirometry reference equations in Marfan syndrome},
	url = {https://m2.mtmt.hu/api/publication/31936034},
	author = {Kolonics-Farkas, Abigél Margit and Jáky-Kováts, Zsuzsanna Ágnes and Bohács, Anikó and Odler, Balázs and Benke, Kálmán and Ágg, Bence and Szabolcs, Zoltán and Müller, Veronika},
	doi = {10.1556/2060.2021.00002},
	journal-iso = {PHYSIOL INT},
	journal = {PHYSIOLOGY INTERNATIONAL},
	volume = {108},
	unique-id = {31936034},
	issn = {2498-602X},
	keywords = {Reference Values; airway obstruction; Spirometry; Marfan syndrome; Global Initiative for Chronic Obstructive Lung Disease; Global Lung initiative},
	year = {2021},
	eissn = {2677-0164},
	pages = {95-105},
	orcid-numbers = {Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Jáky-Kováts, Zsuzsanna Ágnes/0000-0001-6145-6595; Bohács, Anikó/0000-0002-8229-4254; Benke, Kálmán/0000-0001-7885-2543; Ágg, Bence/0000-0002-6492-0426; Müller, Veronika/0000-0002-1398-3187}
}

@article{MTMT:32856966,
	title = {Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features},
	url = {https://m2.mtmt.hu/api/publication/32856966},
	author = {Nagy, Alexandra and Bárczi, Enikő and Kolonics-Farkas, Abigél Margit and Bohács, Anikó and Vincze, Krisztina and Eszes, Noémi and Erdélyi, Tamás and Tárnoki, Ádám Domonkos and Tárnoki, Dávid László and Müller, Veronika},
	doi = {10.1183/13993003.congress-2020.738},
	journal-iso = {EUR RESPIR J},
	journal = {EUROPEAN RESPIRATORY JOURNAL},
	volume = {56},
	unique-id = {32856966},
	issn = {0903-1936},
	year = {2020},
	eissn = {1399-3003},
	orcid-numbers = {Nagy, Alexandra/0000-0001-8713-9256; Bárczi, Enikő/0000-0001-9644-4172; Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Bohács, Anikó/0000-0002-8229-4254; Vincze, Krisztina/0000-0002-3667-5371; Eszes, Noémi/0000-0001-8000-2265; Erdélyi, Tamás/0000-0002-5025-8769; Tárnoki, Ádám Domonkos/0000-0001-5909-3780; Tárnoki, Dávid László/0000-0002-7001-7647; Müller, Veronika/0000-0002-1398-3187}
}

@article{MTMT:31819317,
	title = {Az interstitialis tüdőbetegségek diagnosztikája és az idiopathiás tüdőfibrosis kezelése felnőttekben},
	url = {https://m2.mtmt.hu/api/publication/31819317},
	author = {Kolonics-Farkas, Abigél Margit and Müller, Veronika},
	journal-iso = {ORVOSKÉPZÉS},
	journal = {ORVOSKÉPZÉS},
	volume = {95},
	unique-id = {31819317},
	issn = {0030-6037},
	keywords = {TÜDŐFIBROSIS; interstitialis tüdőbetegség; idiopathiás; diagnosztika},
	year = {2020},
	pages = {609-615},
	orcid-numbers = {Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Müller, Veronika/0000-0002-1398-3187}
}

@article{MTMT:31479556,
	title = {Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE},
	url = {https://m2.mtmt.hu/api/publication/31479556},
	author = {Kolonics-Farkas, Abigél Margit and Sterclova, Martina and Mogulkoc, Nesrin and Kus, Jan and Hajkova, Marta and Müller, Veronika and Jovanovic, Dragana and Tekavec-Trkanjec, Jasna and Littnerova, Simona and Hejduk, Karel and Vasakova, Martina},
	doi = {10.1007/s40264-020-00978-5},
	journal-iso = {DRUG SAFETY},
	journal = {DRUG SAFETY},
	volume = {43},
	unique-id = {31479556},
	issn = {0114-5916},
	abstract = {Introduction Nintedanib, a tyrosine kinase receptor inhibitor, may be associated with increased bleeding risk. Thus, patients with an inherited predisposition to bleeding, or those receiving therapeutic doses of anticoagulants or high-dose antiplatelet therapy, have been excluded from clinical trials of nintedanib in idiopathic pulmonary fibrosis (IPF). Objective Our objective was to examine real-world bleeding events in patients with IPF treated with antifibrotics, including those receiving anticoagulants and/or antiplatelet therapy. Methods The European MultiPartner IPF Registry (EMPIRE) enrolled 2794 patients with IPF: group A (1828: no anticoagulant or antiplatelet treatment), group B (227: anticoagulant treatment), group C (659: antiplatelet treatment), and group D (80: anticoagulant and antiplatelet treatment). Overall, 673 (24.1%) received nintedanib and 933 (33.4%) received pirfenidone. Bleeding events and their relationship to antifibrotic and anticoagulation treatment were characterized. Results Group A patients, versus those in groups B, C, and D, were typically younger and generally had the lowest comorbidity rates. A higher proportion of patients in groups A and C, versus group B, received nintedanib. Pirfenidone, most common in group D, was more evenly balanced across groups. In patients with reported bleeding events, seven of eight received nintedanib (groups A, C, and D). Bleeding incidence was 3.0, 0, 1.3, and 18.1 per 10,000 patient-years (groups A, B, C, and D, respectively). Conclusion Real-world data from EMPIRE showed that patients on anticoagulant medications received nintedanib less frequently, perhaps based on its mechanism of action. Overall, bleeding incidence was low (0.29%: nintedanib 0.25%; pirfenidone 0.04%) and irrespective of anticoagulant or antiplatelet therapy received (P = 0.072).},
	year = {2020},
	eissn = {1179-1942},
	pages = {971-980},
	orcid-numbers = {Kolonics-Farkas, Abigél Margit/0000-0001-8903-2786; Müller, Veronika/0000-0002-1398-3187}
}